Mualliflar

  • Dilnoza Akhrorovna Khasanova
  • Ahtam Istamovich Barnoev

##semicolon##

duodenum, jejunum, ileum, mucosa, pulmonary fibrosis.

##submission.citations##

Basil MC, Levy BD. Specialized prore-solving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16(1):51–67.

Bettenworth, D., and Rieder, F. (2017). Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig. Dis. 35, 25–31.

Dalli J, Vlasakov I, Riley IR, et al. Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages. Proc Natl Acad Sci U S A. 2016;113(43):12232–12237.

Datta A., Scotton C.J., Chambers R.C. Novel therapeutic approaches for pulmonary fibrosis // British Journal of Pharmacology. - 2011. - Vol. 163. -P. 141 - 172.

Di Ciaula, A., Baj, J., Garruti, G., Celano, G., De Angelis, M., Wang, H. H., et al. (2020). Liver steatosis, gutliver axis, microbiome and environmental factors. A neverending bidirectional crosstalk. J. Clin. Med. 9:2648.

Han J, Li H, Bhandari S, et al. Maresin conjugates in tissue regeneration 1 improves alveolar fluid clearance by up-regulating alveolar ENaC, Na, KATPase in lipopolysaccharide-induced acute lung injury. J Cell Mol Med. 2020;24(8):4736–4747.

Li H, Hao Y, Yang LL, et al. MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx. J Cell Physiol. 2020;235(10):7283–7294.

Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36(7):1518–1531.

Meyer KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med. 2017;11(5):343–359.

Pan J, Li X, Wang X, Yang L, Chen H, Su N, Wu C, Hao Y , Jin S , Li H //MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice/Volume 2021:14 Pages 1873—1881

Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–1952.

Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–1952.

Rosenbloom, J., Macarak, E., Piera-Velazquez, S., and Jimenez, S. A. (2017). Human fibrotic diseases: current challenges in fibrosis research. Methods Mol. Biol. 1627, 1–23.

Sabharwal S. «Gastrointestinal Manifestations of Cystic Fibrosis» Gastroenterol Hepatol (N Y). 2016 Jan; 12(1): 43–47.

Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel proresolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200–215.

Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383(10):958–968.

Winter DH, Manzini M, Salge JM, Busse A, Jaluul O, Jacob Filho W, Mathias W, Terra-Filho M. Aging of the lungs in asymptomatic lifelong nonsmokers: findings on HRCT. (2015) Lung. 193 (2): 283-290.

Yang Y, Zhu Y, Xiao J, et al. Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function. Biochem Pharmacol. 2020;177:11-40.

Казымова Д. В. «Интерстициальные болезни легких у детей: Клиниколучевая характеристика» Самара 2015 г., С.79-83.